RHOT2 and cancer: The first report examining MIRO2 in cancer showed that MIRO2 depletion partially reduced tumor cell invasion in PCa cells; however, MIRO2 was dispensable for exacerbated tumor cell invasion induced by depletion of Syntaphilin (19) (Fig. 2).